Multi-site Left Ventricular (MSLV) Pacing With Quartet 1458Q Lead

The purpose of this clinical investigation is to evaluate the safety and hemodynamic performance of the MSLV Pacing feature in a clinical setting.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Multi-site Left Ventricular Pacing

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Herzzentrum, Bad Krozingen, Germany

About this study

To evaluate the hemodynamic impact of different pacing MSLV configurations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Patients who have a recognised indication to receive a CRT-D device or an upgrade from a pacemaker or ICD to a CRT-D system.
Patients have signed an informed consent form indicating their willingness to participate to this study.

Exclusion criteria

Patients who are unable to comply with the follow-up schedule based on their geographic location or for any reason.
Patients with second or third degree AV Block
Patients with intrinsic atrial rhythm < 40 bpm
Patients with a previously implanted left ventricular pacing lead.
Patients who are pregnant.
Patients currently participating in a clinical investigation that includes an active treatment arm.
Patients under 18 years of age.
Patients with a life expectancy of less then 6 months.

Sponsors and collaborators

Lead sponsor

Abbott Medical Devices

Industry

Registry information

Acronym: MSLV

Important dates

Study start: 2010
Primary completion: 2010
Study completion: 2010
First posted: Jan 8, 2010
Registry last updated: Feb 4, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.